Cationic liposomes bearing IL-2 on their external surface induced mice leukocytes to kill human cervical cancer cells in vitro, and significantly reduced tumor burden in immunodepressed mice

Journal of Drug Targeting

Volumn 19, Issue 2, 2011, Pages 79-85

  Rangel Corona, Rosalva ^a   Corona Ortega, Teresa ^a   Del Río Ortiz, Itzel ^a   Nieves Ramírez, Miriam E ^a   Morán Bañuelos, Hirán ^a   González Tenorio, Olivia ^a   Cáceres Cortés, Julio Roberto ^a   Weiss Steider, Benny ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

IL 2 liposomes; Liposomes; Targeted drug delivery; Tumor regression

Indexed keywords

AMINO ACID TRANSPORTER; CYTOTOXIC ANTIBODY; INTERLEUKIN 2 RECEPTOR; LIPOSOME;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER DIAGNOSIS; CANCER INHIBITION; CD8+ T LYMPHOCYTE; CELL INFILTRATION; COCULTURE; CONTROLLED STUDY; FEMALE; IMMUNE DEFICIENCY; IN VITRO STUDY; IN VIVO STUDY; LEUKOCYTE; LYMPHOCYTE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SOLID TUMOR; TUMOR GROWTH; UTERINE CERVIX CANCER;

ANIMALS; ANTINEOPLASTIC AGENTS; CATIONS; CELL LINE, TUMOR; COCULTURE TECHNIQUES; DISEASE MODELS, ANIMAL; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; INTERLEUKIN-2; LEUKOCYTES; LIPOSOMES; LYMPHOCYTES, TUMOR-INFILTRATING; MICE; MICE, INBRED CBA; RECEPTORS, INTERLEUKIN-2; UTERINE CERVICAL NEOPLASMS;

EID: 78650536567     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.3109/10611861003733920     Document Type: Article

References (22)

1. Bao A, Phillips WT, Goins B, Zheng X, Sabour S, Natarajan M, Ross Woolley F, Zavaleta C, Otto RA. (2006). Potential use of drug carried- liposomes for cancer therapy via direct intratumoral injection. Int J Pharm, 316, 162-169. (Pubitemid 43765700)
2. Caceres-Cortes JR, Alvarado-Moreno JA, Waga K, Rangel-Corona R, Monroy-Garcia A, Rocha-Zavaleta L, Urdiales-Ramos J, Weiss- Steider B, Haman A, Hugo P, Brousseau R, Hoang T. (2001). Implication of tyrosine kinase receptor and steel factor in cell density-dependent growth in cervical cancers and leukemias. Cancer Res, 61, 6281-6289. (Pubitemid 32762568)
3. Carloni G, Paterson H, Mareel M, Augery-Bourget Y, Sahraoui J, Rubinstein E, Suarez H, Azzarone B. (1989). N-ras dependent revertant phenotype in human HT1080 fibrosarcoma cells is associated with loss of proliferation within normal tissues and expression of an adult membrane antigenic phenotype. Oncogene, 4, 873-880. (Pubitemid 19176975)
4. Corona-Ortega T, Rangel-Corona R, Hernández-Jiménez M, Baeza I, Ibáñez M, Weiss-Steider B. (2009). Characterization of cationic liposomes having IL-2 expressed on their external surface, and their affinity to cervical cancer cells expressing the IL-2 receptor. J Drug Target, 17, 496-501.
5. Dougan M, Dranoff G. (2009). Immune therapy for cancer. Annu Rev Immunol, 27, 83-117.
6. Engelhard VH, Bullock TN, Colella TA, Mullins DW. (2000). Direct identification of human tumor-associated peptide antigens and a preclinical model to evaluate their use. Cancer J, 6 Suppl 3, S272-S280.
7. Filion MC, Phillips NC. (1997). Anti-inflammatory activity of cationic lipids. Br J Pharmacol, 122, 551-557.
8. Hafez IM, Cullis PR. (2001). Roles of lipid polymorphism in intracellular delivery. Adv Drug Deliv Rev, 47, 139-148.
9. Harada N, Shimada M, Okano S, Suehiro T, Soejima Y, Tomita Y, Maehara Y. (2004). IL-12 gene therapy is an effective therapeutic strategy for hepatocellular carcinoma in immunosuppressed mice. J Immunol, 173, 6635-6644. (Pubitemid 39541047)
10. Kiser M, McCubrey JA, Steelman LS, Shelton JG, Ramage J, Alexander RL, Kucera GL, Pettenati M, Willingham MC, Miller MS, Frankel AE. (2001). Oncogene-dependent engraftment of human myeloid leukemia cells in immunosuppressed mice. Leukemia, 15, 814-818. (Pubitemid 32492705)
11. Kondapaneni M, McGregor JR, Salvemini D, Laubach VE, Samlowski WE. (2008). Inducible nitric oxide synthase (iNOS) is not required for IL-2-induced hypotension and vascular leak syndrome in mice. J Immunother, 31, 325-333. (Pubitemid 351595155)
12. Konigsberg PJ, Godtel R, Kissel T, Richer LL. (1998). The development of IL-2 conjugated liposomes for therapeutic purposes. Biochim Biophys Acta, 1370, 243-251. (Pubitemid 28183976)
13. Kueng W, Silber E, Eppenberger U. (1989). Quantification of cells cultured on 96-well plates. Anal Biochem, 182, 16-19. (Pubitemid 19251274)
14. Muranski P, Boni A, Wrzesinski C, Citrin DE, Rosenberg SA, Childs R, Restifo NP. (2006). Increased intensity lymphodepletion and adoptive immunotherapy-how far can we go? Nat Clin Pract Oncol, 3, 668-681. (Pubitemid 44843125)
15. Poste G. (1980). The interaction of lipid vesicles (liposomes) with cultured cells and their use as carriers for drugs and macromolecules. In: Gregoriadis G, Allison A, eds. Liposomes in Biological Systems. New York: Wiley.
16. Rangel R, Rocha L, Ramirez JL, Ibarra MJ, Solorza G, Monroy A, Ramirez MA, Herrera A, Weiss-Steider B. (1995). Generation of memory CD4+, CD8+, CD45RO+ and CD16- lymphocytes activated with IL-2, INF-gamma, and TNF-alpha with specific cytotoxicity against autologous cervical cancer cells in a mixed leukocyte-tumour cell culture. Eur Cytokine Netw, 6, 195-202.
17. Rangel R, Rodríguez L, Flores G, Gómez C, Soto I, Mendoza F, Weiss B. (1998). Differential expression of the two components of the interleukin- 2 receptor in cervical cancer cells. In: Moraes M, Brentani R, Bevlacqua R, eds. Proceedings of the 17th International Cancer Congress (pp. 1239-1243). Italy: Monduzzi Editore.
18. Seliger B, Schlaf G. (2007). Structure, expression and function of HLA-G in renal cell carcinoma. Semin Cancer Biol, 17, 444-450. (Pubitemid 350052590)
19. Shirai M, Watanabe S, Nishioka M. (1990). Antitumour effect of intratumoral injection of human recombinant interleukin-2 in patients with hepatocellular carcinoma: A preliminary report. Eur J Cancer, 26, 1045-1048.
20. Weissman D, Parker DJ, Rothstein TL, Marshak-Rothstein A. (1985). Methods for the production of xenogeneic monoclonal antibodies in murine ascites. J Immunol, 135, 1001-1003. (Pubitemid 16242789)
21. Yamamoto K, Mizutani Y, Nakanishi H, Fujiwara J, Ishida H, Toiyama D, Abe K, Hayashi I, Okada K, Kawauchi A, Mizuno M, Yoshida J, Miki T. (2008). Significant antitumor activity of cationic multilamellar liposomes containing human interferon-beta gene in combination with 5-fluorouracil against human renal cell carcinoma. Int J Oncol, 33, 565-571.
22. Zhou X, Huang L. (1994). DNA transfection mediated by cationic liposomes containing lipopolylysine: Characterization and mechanism of action. Biochim Biophys Acta, 1189, 195-203. (Pubitemid 24042719)